Siva Vanapalli, Ph.D.
Vitafoods Europe 2023: The Top 4 Trends in Functional Ingredients and Nutraceuticals
Vitafoods Europe 2023 was a great success, and it provided a valuable opportunity for the nutraceutical and functional ingredients community
top of page
NemaLife News
Featured
Featured Stories
Dhaval Patel, Ph.D.
- May 11
How a Tiny Worm is Unlocking the Secrets of Healthy Aging and Longevity
Unveil aging secrets with C. elegans. Discover how studying this tiny worm unlocks longevity insights and fights age-related diseases.
Siva Vanapalli, Ph.D.
- Feb 15
A Recap of the 2023 Probiota Event in Barcelona
The 2023 IPA World Congress + Probiota, brought to you by NutraIngredients, was a big event in the probiotic industry. Here's the recap.
Cision
- Jan 25
NemaLife Develops Second-Generation, AI-Driven High-throughput Organism-on-Chip Screening Platform
Addressing market demand for rapid evaluation of novel ingredients, NemaLife enhances the capabilities of its in vivo screening platform....
NutraIngredients
- Jan 18
Gut health 'pioneer' to showcase large-scale nematode screening platform at Probiota
A startup company providing the nutraceuticals industry with fast and affordable ingredient screening via AI nematode analysis has been...
Newswires
- Sep 13, 2022
NemaLife CTO receives the prestigious REDI award from the National Institute on Aging
NemaLife’s AI-assisted microfluidics-based tech platform receives funding to pursue rapid discovery of drug candidates that could improve...
Google Cloud
- Jun 13, 2022
Google Interviews the NemaLife Team
Google investigates Worms in the Cloud: How nematodes and AI are transforming R&D.
Cision
- May 4, 2022
Motif FoodWorks Announces Strategic Investment in NemaLife, Inc.
The collaboration will support Motif's rapid food-technology product pipeline by utilizing in vivo testing for functional properties of...
Events
Industry Events
Siva Vanapalli, Ph.D.
- May 17
Vitafoods Europe 2023: The Top 4 Trends in Functional Ingredients and Nutraceuticals
Vitafoods Europe 2023 was a great success, and it provided a valuable opportunity for the nutraceutical and functional ingredients community
Siva Vanapalli, Ph.D.
- Apr 3
The Future of FoodTech Conference and Industry Innovations Recap
The 2023 Future of FoodTech conference was held in San Francisco, from March 16-17, with more than 1500 attendees. This conference...
Dhaval Patel, Ph.D.
- Feb 15
High-throughput Tools for Accelerating Discovery in the Biotics Industry
Recently at the IPA World Congress + Probiota 2023 event in Barcelona, I had the opportunity to lead a roundtable discussion on...
Dhaval Patel, Ph.D.
- Feb 15
Being a 2023 Probiota Pioneer at the IPA World Congress + Probiota Event in Barcelona
Recently, NemaLife was selected as a 2023 Probiota Pioneer, which is an award given to innovative start-ups serving the ever-expanding...
Siva Vanapalli, Ph.D.
- Feb 15
A Recap of the 2023 Probiota Event in Barcelona
The 2023 IPA World Congress + Probiota, brought to you by NutraIngredients, was a big event in the probiotic industry. Here's the recap.
NutraIngredients USA
- Nov 3, 2022
NemaLife builds nematode-based ingredient screening pipeline for rapid and actionable results
NemaLife builds nematode-based ingredient screening pipeline for rapid, affordable, and actionable results
NemaLife
- Oct 27, 2022
The 2022 Miami Microbiome Conference
NemaLife attends Miami Microbiome Conference
Awards
Awards
NemaLife
- Oct 24, 2022
Texas Tech University honors NemaLife with the 2022 Startup of the Year
From left to right: Siva Vanapalli, Ph.D., Nicki Vanapalli, Thomas Germain, Tyler Chiriboga, Kylie Harman, Kellen Ketchersid, Adnan...
BioNTX
- Sep 20, 2022
BioNTX Announces Rising Star Awards
2022 Rising Stars Announced at BioNTX’s iC³ Life Science Summit Rising Star Award Every year BioNTX selects Rising Stars in the life...
TTU Daily Dose
- Dec 6, 2019
$100,000 Awarded to High-Performing Texas Tech Startups
Recipients of the Presidents’ Innovation Award are determined by the presidents of Texas Tech University and the Texas Tech University...
Press
Press
NASA
- Dec 20, 2022
Space Station Uses NemaFlex
Loss of muscle mass and strength present a major challenge for astronauts on future long space voyages. Determining Muscle Strength in Space
Newswires
- Sep 27, 2022
NemaLife receives funding to develop a neurotherapeutic discovery platform
NemaLife receives funding to develop a neurotherapeutic discovery platform using next-generation psychedelic compounds. LUBBOCK, TX, USA,...
Newswires
- Sep 13, 2022
NemaLife CTO receives the prestigious REDI award from the National Institute on Aging
NemaLife’s AI-assisted microfluidics-based tech platform receives funding to pursue rapid discovery of drug candidates that could improve...
BioSpace
- Jul 12, 2022
BioSpace Article - Worms: They’re a Lot Like Us, and that’s Good for Drug Development
To most, roundworms, or C. elegans, are just that: microscopic worms that live beneath our feet in the soil. But to scientists and...
Google Cloud
- Jun 13, 2022
Google Interviews the NemaLife Team
Google investigates Worms in the Cloud: How nematodes and AI are transforming R&D.
Cision
- May 4, 2022
Motif FoodWorks Announces Strategic Investment in NemaLife, Inc.
The collaboration will support Motif's rapid food-technology product pipeline by utilizing in vivo testing for functional properties of...
NemaLife
- Apr 19, 2022
DEA registered NemaLife Inc. to work with Schedule 1 substances
NemaLife Inc., completed its DEA schedule 1 registration. If you have scheduled compounds (schedule 1-5) to test, reach out to our...
-
- Apr 19, 2022
NemaLife & UC Davis enter into research partnership
NemaLife and UC Davis enter into a research partnership to test the therapeutic potential of several novel psychoplastogens developed in...
New Hope Network
- Apr 7, 2022
Artificial intelligence discovers ingredients for food, supplements
Using AI, companies survey thousands of plant compounds to quickly and automatically identify potential ingredients for use in foods and...
Press
- Mar 14, 2022
Canopy Growth presents toxicity data of cannabigerol in C. elegans
Canopy Growth Corporation's Vice President of Human & Animal Research, Dr. Marcel Bonn-Miller is giving a talk about the long-term...
NemaLife
- Jan 18, 2022
DEA registered NemaLife Inc. to work with Schedule 2-5 substances
NemaLife Inc., completed its DEA schedule 2-5 registration. If you have scheduled compounds to test reach out to our expert for a free...
NASA
- Jul 20, 2021
Innovative Tech Measures Muscle Strength of Worms in Space to Prepare Astronauts for Future Missions
Loss of muscle mass and strength in astronauts remains an issue for space exploration. C. elegans shares common traits with humans and...
Canopy Growth
- Nov 20, 2020
First research completed on the whole-life toxicity of CBD
Canopy Growth Corporation and its medical division, Spectrum Therapeutics, have completed and published a new study on the long-term...
Nature
- Oct 23, 2020
Worm-on-Chip Platform for long term culture and study
A microfluidic platform for long term culture and study of C. elegans Posted at 17:19h in Latest Research by Pouriya Bayat The short life...
Longevity.Technology
- Mar 26, 2020
Chemical screening to find hidden Longevity gems?
Start-up NemaLife evolves from platform technology to services provider to identify chemicals that have both positive and negative...
TTU Daily Dose
- Dec 6, 2019
$100,000 Awarded to High-Performing Texas Tech Startups
Recipients of the Presidents’ Innovation Award are determined by the presidents of Texas Tech University and the Texas Tech University...
Hub City Spokes
- Dec 4, 2019
Hub City Spokes interviews NemaLife's, CEO Siva Vanapalli, Ph.D.
Katherine White sits down with Siva Vanapalli, a professor of chemical engineering at Texas Tech University and also Co-founder and CEO...
Lubbock Avalanche Journal
- Nov 7, 2019
People helping people is core of Texas Tech Innovation Hub
People helping people is core of Texas Tech Innovation Hub
Industry
Industry
Dhaval Patel, Ph.D.
- May 11
How a Tiny Worm is Unlocking the Secrets of Healthy Aging and Longevity
Unveil aging secrets with C. elegans. Discover how studying this tiny worm unlocks longevity insights and fights age-related diseases.
Dhaval Patel, Ph.D.
- Feb 15
High-throughput Tools for Accelerating Discovery in the Biotics Industry
Recently at the IPA World Congress + Probiota 2023 event in Barcelona, I had the opportunity to lead a roundtable discussion on...
Dhaval Patel, Ph.D.
- Feb 15
Being a 2023 Probiota Pioneer at the IPA World Congress + Probiota Event in Barcelona
Recently, NemaLife was selected as a 2023 Probiota Pioneer, which is an award given to innovative start-ups serving the ever-expanding...
Siva Vanapalli, Ph.D.
- Feb 15
A Recap of the 2023 Probiota Event in Barcelona
The 2023 IPA World Congress + Probiota, brought to you by NutraIngredients, was a big event in the probiotic industry. Here's the recap.
NemaLife
- Sep 30, 2022
An amendment that will impact regulations for testing the safety & efficacy of drugs and ingredients
Yesterday, the US Senate unanimously approved the FDA Modernization Act 2.0, which was previously approved by the Lower House. This new...
UMass Chan Medical School
- Jul 7, 2022
Collaborative effort led by Marian Walhout spotlights worms as model for personalized medicine
Multidisciplinary collaboration develops C. elegans as a model for investigating metabolism variations between individuals Using four...
NemaLife
- Jun 9, 2022
US House Passes Legislation to End FDA Animal Testing Mandate
FDA Modernization Act rider will spare animals, drive down drug prices and produce safer treatments and cures By EP News Bureau on June...
NIH
- Apr 1, 2022
New Approaches for Incorporating Genetic Diversity into Toxicity Testing
Our study aims to combine state-of-the art advances in microfluidics, computer vision, laboratory automation, and a massively curated...
Canopy Growth
- Nov 20, 2020
First research completed on the whole-life toxicity of CBD
Canopy Growth Corporation and its medical division, Spectrum Therapeutics, have completed and published a new study on the long-term...
Company
Company
Dhaval Patel, Ph.D.
- May 11
How a Tiny Worm is Unlocking the Secrets of Healthy Aging and Longevity
Unveil aging secrets with C. elegans. Discover how studying this tiny worm unlocks longevity insights and fights age-related diseases.
Dhaval Patel, Ph.D.
- Feb 15
High-throughput Tools for Accelerating Discovery in the Biotics Industry
Recently at the IPA World Congress + Probiota 2023 event in Barcelona, I had the opportunity to lead a roundtable discussion on...
Dhaval Patel, Ph.D.
- Feb 15
Being a 2023 Probiota Pioneer at the IPA World Congress + Probiota Event in Barcelona
Recently, NemaLife was selected as a 2023 Probiota Pioneer, which is an award given to innovative start-ups serving the ever-expanding...
Siva Vanapalli, Ph.D.
- Feb 15
A Recap of the 2023 Probiota Event in Barcelona
The 2023 IPA World Congress + Probiota, brought to you by NutraIngredients, was a big event in the probiotic industry. Here's the recap.
NemaLife
- Sep 30, 2022
An amendment that will impact regulations for testing the safety & efficacy of drugs and ingredients
Yesterday, the US Senate unanimously approved the FDA Modernization Act 2.0, which was previously approved by the Lower House. This new...
UMass Chan Medical School
- Jul 7, 2022
Collaborative effort led by Marian Walhout spotlights worms as model for personalized medicine
Multidisciplinary collaboration develops C. elegans as a model for investigating metabolism variations between individuals Using four...
NemaLife
- Jun 9, 2022
US House Passes Legislation to End FDA Animal Testing Mandate
FDA Modernization Act rider will spare animals, drive down drug prices and produce safer treatments and cures By EP News Bureau on June...
NIH
- Apr 1, 2022
New Approaches for Incorporating Genetic Diversity into Toxicity Testing
Our study aims to combine state-of-the art advances in microfluidics, computer vision, laboratory automation, and a massively curated...
Canopy Growth
- Nov 20, 2020
First research completed on the whole-life toxicity of CBD
Canopy Growth Corporation and its medical division, Spectrum Therapeutics, have completed and published a new study on the long-term...
bottom of page